Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Alpha-interferon and its effects on signalling pathways within cells.
Caraglia M, Vitale G, Marra M, Budillon A, Tagliaferri P, Abbruzzese A. Caraglia M, et al. Among authors: abbruzzese a. Curr Protein Pept Sci. 2004 Dec;5(6):475-85. doi: 10.2174/1389203043379378. Curr Protein Pept Sci. 2004. PMID: 15581417 Review.
Chemotherapy regimen GOLF induces apoptosis in colon cancer cells through multi-chaperone complex inactivation and increased Raf-1 ubiquitin-dependent degradation.
Caraglia M, Marra M, Budillon A, Meo G, Ricciardiello F, Bismuto E, Brachelente G, Francini G, Giordano A, Correale P, Abbruzzese A. Caraglia M, et al. Among authors: abbruzzese a. Cancer Biol Ther. 2005 Oct;4(10):1159-67. doi: 10.4161/cbt.4.10.2206. Epub 2005 Oct 23. Cancer Biol Ther. 2005. PMID: 16294035 Free article.
The farnesyltransferase inhibitor R115777 (ZARNESTRA) enhances the pro-apoptotic activity of interferon-alpha through the inhibition of multiple survival pathways.
Caraglia M, Marra M, Viscomi C, D'Alessandro AM, Budillon A, Meo G, Arra C, Barbieri A, Rapp UR, Baldi A, Tassone P, Venuta S, Abbruzzese A, Tagliaferri P. Caraglia M, et al. Among authors: abbruzzese a. Int J Cancer. 2007 Nov 15;121(10):2317-30. doi: 10.1002/ijc.22964. Int J Cancer. 2007. PMID: 17657738
Protein kinase A as a biological target in cancer therapy.
Naviglio S, Caraglia M, Abbruzzese A, Chiosi E, Di Gesto D, Marra M, Romano M, Sorrentino A, Sorvillo L, Spina A, Illiano G. Naviglio S, et al. Among authors: abbruzzese a. Expert Opin Ther Targets. 2009 Jan;13(1):83-92. doi: 10.1517/14728220802602349. Expert Opin Ther Targets. 2009. PMID: 19063708 Review.
Chemo-immunotherapy: a new option for non-small cell lung cancer.
Vitale G, Abbruzzese A, Tonini G, Santini D. Vitale G, et al. Among authors: abbruzzese a. Cancer Biol Ther. 2009 Mar 15;8(6):503-4. doi: 10.4161/cbt.8.6.7770. Epub 2009 Mar 15. Cancer Biol Ther. 2009. PMID: 19242127 Free article. No abstract available.
Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab and has strong antitumor activity in advanced non-small-cell-lung cancer patients.
Correale P, Remondo C, Carbone SF, Ricci V, Migali C, Martellucci I, Licchetta A, Addeo R, Volterrani L, Gotti G, Rotundo MS, Tassone P, Sperlongano P, Abbruzzese A, Caraglia M, Tagliaferri P, Francini G. Correale P, et al. Among authors: abbruzzese a. Cancer Biol Ther. 2010 May 1;9(9):685-93. doi: 10.4161/cbt.9.9.11441. Cancer Biol Ther. 2010. PMID: 20697196 Free article. Clinical Trial.
The role of tissue microarray in the era of target-based agents.
Franco R, Caraglia M, Facchini G, Abbruzzese A, Botti G. Franco R, et al. Among authors: abbruzzese a. Expert Rev Anticancer Ther. 2011 Jun;11(6):859-69. doi: 10.1586/era.11.65. Expert Rev Anticancer Ther. 2011. PMID: 21707283 Review.
180 results